139 related articles for article (PubMed ID: 15937151)
1. The role of central and peripheral mu opioid receptors in inflammatory pain and edema: a study using morphine and DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-3-yl]-acetic acid).
Whiteside GT; Boulet JM; Walker K
J Pharmacol Exp Ther; 2005 Sep; 314(3):1234-40. PubMed ID: 15937151
[TBL] [Abstract][Full Text] [Related]
2. DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted mu opioid agonist with antihyperalgesic activity: I. In vitro pharmacological characterization and pharmacokinetic properties.
Valenzano KJ; Miller W; Chen Z; Shan S; Crumley G; Victory SF; Davies E; Huang JC; Allie N; Nolan SJ; Rotshteyn Y; Kyle DJ; Broglé K
J Pharmacol Exp Ther; 2004 Aug; 310(2):783-92. PubMed ID: 15054115
[TBL] [Abstract][Full Text] [Related]
3. DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted Mu opioid agonist with antihyperalgesic activity: II. In vivo pharmacological characterization in the rat.
Whiteside GT; Harrison JE; Pearson MS; Chen Z; Fundytus ME; Rotshteyn Y; Turchin PI; Pomonis JD; Mark L; Walker K; Broglé KC
J Pharmacol Exp Ther; 2004 Aug; 310(2):793-9. PubMed ID: 15054116
[TBL] [Abstract][Full Text] [Related]
4. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
[TBL] [Abstract][Full Text] [Related]
5. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat.
Fürst S; Riba P; Friedmann T; Tímar J; Al-Khrasani M; Obara I; Makuch W; Spetea M; Schütz J; Przewlocki R; Przewlocka B; Schmidhammer H
J Pharmacol Exp Ther; 2005 Feb; 312(2):609-18. PubMed ID: 15383636
[TBL] [Abstract][Full Text] [Related]
6. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a selective role of the delta-opioid agonist [8R-(4bS*,8aalpha,8abeta, 12bbeta)]7,10-Dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9H)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]isoquinoline hydrochloride (SB-235863) in blocking hyperalgesia associated with inflammatory and neuropathic pain responses.
Petrillo P; Angelici O; Bingham S; Ficalora G; Garnier M; Zaratin PF; Petrone G; Pozzi O; Sbacchi M; Stean TO; Upton N; Dondio GM; Scheideler MA
J Pharmacol Exp Ther; 2003 Dec; 307(3):1079-89. PubMed ID: 14551288
[TBL] [Abstract][Full Text] [Related]
8. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain.
Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C
Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903
[TBL] [Abstract][Full Text] [Related]
9. Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats.
Gmerek DE; Cowan A; Woods JH
J Pharmacol Exp Ther; 1986 Jan; 236(1):8-13. PubMed ID: 3941402
[TBL] [Abstract][Full Text] [Related]
10. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
Al-Khrasani M; Spetea M; Friedmann T; Riba P; Király K; Schmidhammer H; Furst S
Brain Res Bull; 2007 Oct; 74(5):369-75. PubMed ID: 17845912
[TBL] [Abstract][Full Text] [Related]
11. The analgesic actions of centrally administered celecoxib are mediated by endogenous opioids.
Rezende RM; Dos Reis WG; Duarte ID; Lima PP; Bakhle YS; de Francischi JN
Pain; 2009 Mar; 142(1-2):94-100. PubMed ID: 19186002
[TBL] [Abstract][Full Text] [Related]
12. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model.
Mecs L; Tuboly G; Nagy E; Benedek G; Horvath G
Anesth Analg; 2009 Oct; 109(4):1297-304. PubMed ID: 19762760
[TBL] [Abstract][Full Text] [Related]
13. Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice.
D'Agostino G; La Rana G; Russo R; Sasso O; Iacono A; Esposito E; Raso GM; Cuzzocrea S; Lo Verme J; Piomelli D; Meli R; Calignano A
J Pharmacol Exp Ther; 2007 Sep; 322(3):1137-43. PubMed ID: 17565008
[TBL] [Abstract][Full Text] [Related]
14. The mu opioid receptor mediates morphine-induced tumor necrosis factor and interleukin-6 inhibition in toll-like receptor 2-stimulated monocytes.
Bonnet MP; Beloeil H; Benhamou D; Mazoit JX; Asehnoune K
Anesth Analg; 2008 Apr; 106(4):1142-9, table of contents. PubMed ID: 18349186
[TBL] [Abstract][Full Text] [Related]
15. The novel inhibitor of the heterotrimeric G-protein complex, BIM-46187, elicits anti-hyperalgesic properties and synergizes with morphine.
Favre-Guilmard C; Zeroual-Hider H; Soulard C; Touvay C; Chabrier PE; Prevost G; Auguet M
Eur J Pharmacol; 2008 Oct; 594(1-3):70-6. PubMed ID: 18664366
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
Gallantine EL; Meert TF
Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats.
Fecho K; Maslonek KA; Dykstra LA; Lysle DT
J Pharmacol Exp Ther; 1996 Feb; 276(2):626-36. PubMed ID: 8632330
[TBL] [Abstract][Full Text] [Related]
18. Peripheral antinociceptive effects of mu- and delta-opioid receptor agonists in NOS2 and NOS1 knockout mice during chronic inflammatory pain.
Leánez S; Hervera A; Pol O
Eur J Pharmacol; 2009 Jan; 602(1):41-9. PubMed ID: 19041302
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin inhibits inflammatory pain in rats: involvement of the opioid system.
Sibilia V; Lattuada N; Rapetti D; Pagani F; Vincenza D; Bulgarelli I; Locatelli V; Guidobono F; Netti C
Neuropharmacology; 2006 Sep; 51(3):497-505. PubMed ID: 16759671
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of intestinal dysmotility in morphine dependence: whether central or peripheral?
Banach T; Ferreira CE; Weisbrodt NW; Rosenfeld G; Thor PJ
Folia Med Cracov; 2005; 46(1-2):75-82. PubMed ID: 17037289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
